title: [Positron emission tomography/computed tomography in follow-up programmes for patients with colorectal cancer].
abstract: The current follow-up programmes for patients with colorectal cancer (CRC) after curative surgery do not include 18F-fluorodeoxyglucose-positron emission tomography (PET). Several small studies on selected patient populations indicate a high sensitivity of PET/computed tomography (CT) on visualizing relapse in patients with CRC after curative surgery. Therefore, PET/CT could probably be valuable in patients with unexplained increase in carcinoembryonic antigen level or a clinical suspicion of relapse, but PET/CT is not recommended as a standard in follow-up after CRC.
authors.affiliation: annefogh@dadlnet.dk.
authors.forename: Anne Fogh
authors.initials: AF
authors.lastname: Hansen
authors.forename: Mads Radmer
authors.initials: MR
authors.lastname: Jensen
authors.forename: Andreas
authors.initials: A
authors.lastname: Nordholm-Carstensen
mesh_terms: D000359:Aftercare; D015179:Colorectal Neoplasms / Q000000981:diagnostic imaging*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging*; D000072078:Positron Emission Tomography Computed Tomography; D017410:Practice Guidelines as Topic; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18